Compare PHVS & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHVS | CWH |
|---|---|---|
| Founded | 2015 | 1966 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 363.8M |
| IPO Year | 2020 | 2016 |
| Metric | PHVS | CWH |
|---|---|---|
| Price | $31.98 | $5.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $41.82 | $15.78 |
| AVG Volume (30 Days) | 1.0M | ★ 1.8M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 3.99 |
| Revenue | N/A | ★ $4,792,017,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | N/A | $5.72 |
| P/E Ratio | ★ N/A | $1.35 |
| Revenue Growth | N/A | ★ 11.83 |
| 52 Week Low | $20.65 | $4.93 |
| 52 Week High | $43.25 | $17.15 |
| Indicator | PHVS | CWH |
|---|---|---|
| Relative Strength Index (RSI) | 33.82 | 35.63 |
| Support Level | $25.17 | N/A |
| Resistance Level | $33.33 | $6.95 |
| Average True Range (ATR) | 1.90 | 0.32 |
| MACD | -0.70 | -0.08 |
| Stochastic Oscillator | 8.90 | 17.17 |
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
Camping World Holdings Inc is a retailer of RVs and related products and services. The company offers RV products and services with a national network of RV dealerships, service centers and customer support centers. It operates in two reportable segments: Good Sam Services and Plans; and RV and Outdoor Retail. The majority of the revenue is derived from RV and Outdoor Retail segment that derives revenue from the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, and supplies; the sale of outdoor products, equipment, gear and supplies; and the sale of Good Sam Club memberships and co-branded credit cards.